151 related articles for article (PubMed ID: 30074406)
1. LncRNA GAS5 Indel Genetic Polymorphism Contributes to Glioma Risk Through Interfering Binding of Transcriptional Factor TFAP2A.
Yuan J; Zhang N; Zheng Y; Chen YD; Liu J; Yang M
DNA Cell Biol; 2018 Sep; 37(9):750-757. PubMed ID: 30074406
[TBL] [Abstract][Full Text] [Related]
2. A Functional Polymorphism rs145204276 in the Promoter of Long Noncoding RNA GAS5 Is Associated with an Increased Risk of Ischemic Stroke.
Zheng Z; Liu S; Wang C; Han X
J Stroke Cerebrovasc Dis; 2018 Dec; 27(12):3535-3541. PubMed ID: 30197169
[TBL] [Abstract][Full Text] [Related]
3. A Genetic Variant of rs145204276 in the Promoter Region of Long Noncoding RNA GAS5 Is Associated With a Reduced Risk of Breast Cancer.
Tang Y; Wang Y; Wang X; Liu Y; Zheng K
Clin Breast Cancer; 2019 Jun; 19(3):e415-e421. PubMed ID: 30846409
[TBL] [Abstract][Full Text] [Related]
4. Influence of a 5-bp Indel Polymorphism at Promoter of the GAS5 lncRNA and Risk of Breast Cancer.
Sharifi R; Shahangian SS; Salehi Z; Mashayekhi F; Talesh Sasani S; Mirzanezhad L
Asian Pac J Cancer Prev; 2020 Dec; 21(12):3705-3710. PubMed ID: 33369471
[TBL] [Abstract][Full Text] [Related]
5. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
[TBL] [Abstract][Full Text] [Related]
6. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
Shen Z; She Q
Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
[TBL] [Abstract][Full Text] [Related]
7. Polymorphism in the promoter region of lncRNA GAS5 is functionally associated with the risk of gastric cancer.
Li Q; Ma G; Sun S; Xu Y; Wang B
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):478-482. PubMed ID: 29602737
[TBL] [Abstract][Full Text] [Related]
8. Impact of GAS5 genetic polymorphism on prostate cancer susceptibility and clinicopathologic characteristics.
Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
Int J Med Sci; 2019; 16(11):1424-1429. PubMed ID: 31673232
[TBL] [Abstract][Full Text] [Related]
9. Growth arrest-specific 5 (GAS5) insertion/deletion polymorphism and cancer susceptibility in Asian populations: A meta-analysis.
Gao G; Liu C; Li X; Guan X; Yang X; Qin P
Medicine (Baltimore); 2021 Oct; 100(41):e27415. PubMed ID: 34731115
[TBL] [Abstract][Full Text] [Related]
10. LncRNA GAS5 contributes to lymphatic metastasis in colorectal cancer.
Zheng Y; Song D; Xiao K; Yang C; Ding Y; Deng W; Tong S
Oncotarget; 2016 Dec; 7(50):83727-83734. PubMed ID: 27863421
[TBL] [Abstract][Full Text] [Related]
11. Association of LncRNA-GAS5 gene polymorphisms and PBMC LncRNA-GAS5 level with risk of systemic lupus erythematosus in Chinese population.
Liu CH; Lu YL; Huang HT; Wang CF; Luo HC; Wei GJ; Lei M; Tan T; Wang Y; Huang YY; Wei YS; Lan Y
J Cell Mol Med; 2021 Apr; 25(7):3548-3559. PubMed ID: 33728802
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-GAS5 and its Promoter Region Polymorphism Associate with Helper Th17 Polarization and Predict Postoperative Pain and the Prognosis of the Patients with Hepatocellular Carcinoma Undergoing Hepatectomy.
Sha Z; Zhang P
Iran J Immunol; 2022 Dec; 19(4):349-357. PubMed ID: 36585876
[TBL] [Abstract][Full Text] [Related]
13. Association between long non-coding RNA (lncRNA) GAS5 polymorphism rs145204276 and cancer risk.
Zhao S; Liu P; Ruan Z; Li J; Zeng S; Zhong M; Tang L
J Int Med Res; 2021 Sep; 49(9):3000605211039798. PubMed ID: 34521242
[TBL] [Abstract][Full Text] [Related]
14. Genetic Variants of
Deng F; Zhu P; Liao C; Li S; Hu X; Wang Y; Wu Z; Huang S; Zhong W; Zhao B; Ma G; Li Y
Biomed Res Int; 2021; 2021():6634253. PubMed ID: 33937403
[TBL] [Abstract][Full Text] [Related]
15. Correlations of an Insertion/Deletion Polymorphism (rs10680577) in the RERT-lncRNA with the Susceptibility, Clinicopathological Features, and Prognosis of Lung Cancer.
Zhu J; Luo JZ; Li CB
Biochem Genet; 2019 Feb; 57(1):147-158. PubMed ID: 30073577
[TBL] [Abstract][Full Text] [Related]
16. The relationship between functional promoter -94 ins/del ATTG polymorphism in NF-κ B1 gene and the risk of urinary cancer.
Li X; Gao Y; Zhou H; Xu W; Li P; Zhou J; Xu T; Yu B; Xu Z; Zou Q; Yin C; Cai H; Shen W
Cancer Biomark; 2016; 16(1):11-7. PubMed ID: 26484607
[TBL] [Abstract][Full Text] [Related]
17. The Variant rs145204276 of GAS5 is Associated with the Development and Prognosis of Gastric Cancer.
Li QJ; Ma G; Guo HM; Sun SH; Xu Y; Wang BJ
J Gastrointestin Liver Dis; 2018 Mar; 27(1):19-24. PubMed ID: 29557411
[TBL] [Abstract][Full Text] [Related]
18. Association of the lncRNA-GAS5 promoter region rs145204276 polymorphism with sevoflurane maintenance anesthesia outcomes on patients undergoing laparoscopic cholecystectomy.
Zhang P; Sha Z
Saudi Med J; 2023 Feb; 44(2):137-144. PubMed ID: 36773978
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GAS5 rs145204276 Polymorphism Reduces Renal Cell Carcinoma Susceptibility in Southern Chinese Population.
Xiang X; Chen L; He J; Ma G; Li Y
J Inflamm Res; 2022; 15():1147-1158. PubMed ID: 35210817
[TBL] [Abstract][Full Text] [Related]
20. Impact of LncRNA GAS5 Genetic Variants and the Epidermal Growth Factor Receptor Phenotypes on the Clinicopathological Characteristics of Lung Adenocarcinoma Patients.
Hsieh MH; Wu YL; Tsao TC; Huang YW; Lin JC; Lee CY; Hsieh MJ; Yang SF
Int J Environ Res Public Health; 2022 Aug; 19(16):. PubMed ID: 36011604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
